 So what's key, both of our guests say, is changing the way the FDA looks at the effectiveness of some of these drugs long term. And I do want to say we did get a response from the FDA regarding some of these things. And part of what the FDA said was, quote, it does not develop drugs or drug endpoints. The response also pointed out that the FDA has held workshops with the participation of several stakeholders involved.